<DOC>
	<DOCNO>NCT00347737</DOCNO>
	<brief_summary>The purpose study determine effect teriparatide vascular ( blood vessel ) compliance osteoprotegerin ( bone fluid ) RANKL level ( bone cell ) .</brief_summary>
	<brief_title>The Effects Therapy With Teriparatide Vascular Compliance Osteoprotegerin/RANKL</brief_title>
	<detailed_description>Research subject participation 6 month . Subjects give daily injection teriparatide instruction technique .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Postmenopausal woman men age 40 start therapy teriparatide Patients diabetes mellitus current smoker patient history organ transplantation Patients currently previously glucocorticoid therapy within past year Patients serum creatinine 1.5 mg/dl , patient uncontrolled hypertension ( BP 140/90 great ) Patients ineligible teriparatide therapy : History metabolic bone disease osteoporosis History radiation therapy Patients pregnant nursing History bone metastasis skeletal malignancy History hypercalcemia</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>